a prospective , randomized , single-center efficacy and safety comparison was conducted of intravenous ciprofloxacin , 200 mg every 12 hours , and ceftazidime , 2 g every eight hours , as initial empirical therapy in neutropenic patients with fever .
C0008809
ciprofloxacin
C0015967
fever